2 min listen
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang
ratings:
Length:
23 minutes
Released:
Apr 11, 2024
Format:
Podcast episode
Description
In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead engineered hematopoietic cell (eHSC) product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast Host, Erin Harris, about how Vor has treated 8 patients demonstrating clinical proof of concept and is also in the clinic with a CAR-T that could be used in combination with shielded stem cell transplants. They also talk through Vor’s decision to build an internal cell therapy manufacturing facility co-located with their Cambridge, MA-based headquarters.
Released:
Apr 11, 2024
Format:
Podcast episode
Titles in the series (76)
Introducing Cell & Gene: The Podcast by Cell & Gene: The Podcast